BenevolentAI

1 solution $400M+

Solutions (1)

Knowledge graph-driven drug discovery. Identified baricitinib for COVID-19 treatment. Focuses on neurology, inflammation, and oncology targets.

Founded as AI-first drug discovery company. Knowledge graph + ML for target discovery is the core technology.

View full AI profile ▾